Anthony D'Amico, MD, PHD
Anthony D’Amico is the Eleanor Theresa Walters Distinguished Chair and Chief of Genitourinary Radiation Oncology at the Dana-Farber Cancer Institute and Brigham and Women’s Hospital. Dr. D’Amico is an internationally known expert in the treatment of prostate cancer and has defined combined modality staging, which is used to select patients with localized prostate cancer for specific surgical or radiotheraputic treatment options. He is the principal investigator of several federally funded grants that support his investigations in Image Guided Therapy for early stage prostate cancer, drug development for advanced stage prostate cancer, and clinical trials that are aimed at defining future management strategies for men with prostate cancer. Dr. D’Amico has over 300 peer reviewed original publications and editorials, and his teaching contributions include his position as Co-director of the Harvard Combined Residency in Radiation Oncology, Master of the Oliver Wendell Holmes Society at Harvard Medical School, editorial board member of 6 scientific journals, expert reviewer for 14 Journals including the New England Journal of Medicine and the Journal of the American Medical Association and editor of four textbooks on the management of prostate cancer. Dr. D’Amico has been awarded the Best Doctor in America award annually since 2009 for his work in prostate cancer, is the 2012 Harvard Medical School Arnold P. Gold Awardee for Humanism in Medicine and the recipient of the Harvard Medical School Class of 2014, 2015 and 2016 Career Advising and Mentoring Faculty Teaching Award in addition to the 2015-2016 Morton M. Kligerman Award provided by the Hospital of the University of PA.
No financial relationships have been disclosed.